Welcome to the investor relations center of Accelerate Diagnostics, Inc. Here you will find a wealth of information regarding the company’s performance to date, recent filings, and our strategy for the continued growth of our business.
Accelerate Diagnostics, Inc. is an in-vitro diagnostics company dedicated to providing solutions for the global challenge of antibiotic resistance and hospital acquired infections. Our focus is developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens.
If you have questions or comments please contact our Investor Relations team by clicking here. We will be happy to help!
Aug 3, 2017
Accelerate Diagnostics Reports Q2 2017 Financial Results, Doubles Revenue Generating Placements
Jul 31, 2017
Accelerate Diagnostics Welcomes Dr. Romney Humphries as Chief Scientific Officer
Jul 18, 2017
Accelerate Diagnostics Schedules Call to Review Second Quarter 2017 Results for August 3rd
View Latest Presentation ›
Listen to the recent webcast
Day Low: 21.65